Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapy

Archives of Virology

Volumn 150, Issue 9, 2005, Pages 1885-1902

  Parr, E L ^a   Holliday, E M ^a   Collard, M W ^a   Parr, M B ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; DRUG DERIVATIVE; GLYCOPROTEIN D HERPES SIMPLEX VIRUS TYPE 2; GLYCOPROTEIN D-HERPES SIMPLEX VIRUS TYPE 2; MONOCLONAL ANTIBODY; VALACICLOVIR; VALINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG COMBINATION; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; RECURRENT DISEASE; VIROLOGY; VIRUS LATENCY;

ACYCLOVIR; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; RECURRENCE; VALINE; VIRAL ENVELOPE PROTEINS; VIRUS LATENCY;

HERPES; HUMAN HERPESVIRUS 2;

EID: 23844444109     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-005-0524-y     Document Type: Article

References (38)

1. EM Cantin DR Hinton J Chen H Openshaw 1995 Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol 69 4898 4905
2. E Cantin B Tanamachi H Openshaw 1999 Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J Virol 73 3418 3423
3. L Corey PG Spear 1986a Infections with herpes simplex viruses, part 1. N Engl J Med 314 686 691
4. L Corey PG Spear 1986b Infections with herpes simplex viruses, part 2. N Engl J Med 314 749 757
5. WB Davis JA Taylor JE Oakes 1979 Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody. J Infect Dis 140 534 540
6. RD Dix L Pereira JR Baringer 1981 Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun 34 192 199
7. S Efstathiou HJ Field PO Griffiths ER Kern SL Sacks NM Sawtell LR Stanberry 1999 Herpes simplex virus latency and nucleoside analogues. Antiviral Res 41 85 100
8. RM Greenblatt SA Lukehart FA Plummer TC Quinn CW Critchlow RL Ashley LJ D'Costa JO Ndinya-Achola L Corey AR Ronald 1988 Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 2 47 50
9. WP Halford BM Gebhardt DJ Carr 1996 Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 157 3542 3549
10. RA LeBlanc L Pesnicak M Godleski SE Straus 1999 Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation. Virol 262 230 236
11. + T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191 1459 1466
12. T Liu KM Khanna BN Corriere RL Hendricks 2001 Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol 75 11178 11184
13. J Maggioncalda A Mehta YH Su NW Fraser TM Block 1996 Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology 225 72 81
14. JR Martin EV Reed 1986 Central nervous system and genital infection with reactivation of latent herpes simplex virus type 2 in mice. Microb Pathogenesis 1 181 189
15. JR Martin S Suzuki 1987 Inflammatory sensory polyradiculopathy and reactivated peripheral nervous system infection in a genital herpes model. J Neurol Sci 79 155 171
16. MR McDermott BJ Smiley PLJ Brais H Rudzroga J Bienenstock 1984 Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J Virol 51 247 253
17. MR McDermott PLJ Brais GC Goettsche MJ Evelegh CH Goldsmith 1987 Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes. Arch Virol 93 51 68
18. AJ Nahmias FK Lee S Bechman-Nahmias 1990 Sero-epidemiological and - sociological patterns of herpes simplex virus infection in the world. Scand J Inf Dis Supp 69 19 36
19. AA Nash 2000 T cells and the regulation of herpes simplex virus latency and reactivation. J Exp Med 191 1455 1457
20. MB Parr L Kepple MR McDermott MD Drew JJ Bozzola EL Parr 1994 A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest 70 369 380
21. MB Parr EL Parr 1998 Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J Virol 72 2677 2685
22. EL Parr MB Parr 1999 Immune response and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type 2. Immunol 98 639 645
23. MB Parr EL Parr 2003 Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites. J Neurovirol 9 594 602
24. Parr EL, Parr MB (2005) Female genital tract infections and immunity in animal models. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds) Mucosal immunology, vol 3. Elsevier, Amsterdam
25. J Podlech F Hengerer M Fleck J Kunkel D Falke 1997 Localization of latency-associated transcripts in the uterovaginal plexus of herpes simplex virus type 1 and 2 latently infected mice. J Gen Virol 78 1103 1108
26. RW Price AL Notkins 1977 Viral infections of the autonomic nervous system and its target organs: pathogenetic mechanisms. Med Hypoth 3 33 36
27. GV Quinnan H Masur AH Rook G Armstrong WR Frederick J Epstein JF Manischewitz AM Macher L Jackson J Ames HA Smith M Parker GR Pearson J Parillo C Mitchell SE Straus 1984 Herpes virus infection in acquired immune deficiency. J Am Med Assoc 252 72 77
28. NM Sawtell 1998 The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglion. J Virol 72 6888 6892
29. NM Sawtell DK Poon CS Tansky RL Thompson 1998 The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol 72 5343 5350
30. C Shimeld JL Whiteland SM Nicholls E Grinfeld DL Easty H Gao TJ Hill 1995 Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol 61 7 16
31. A Simmons AA Nash 1984 Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol 52 816 821
32. + T cell-mediated protective immunity against herpes simplex virus-2 challenge. J Immunol 162 2912 2921
33. LR Stanberry ER Kern JT Richards TM Abbott JC Overall 1982 Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis 146 397 404
34. LR Stanberry 1991 Evaluation of herpes simplex virus vaccines in animals: the guinea pig vaginal model. Rev Infect Dis 13 5920 5923
35. T Valyi-Nagi SJ Olson K Valyi-Nagi TJ Montine TS Dermody 2000 Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology 278 309 321
36. MA Walz 1977 Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2. J Infect Dis 135 744 752
37. R Whitley A Arvin C Prober 1991 Predictors of morbidity and mortality in neonates with herpes simplex virus infection. N Eng J Med 154 415 421
38. H Wrzos F Rapp 1985 Experimental model for activation of genital herpes simplex virus. J Infect Dis 151 349 354